RLS Global: Platform Potential
Initiating Coverage
2020-04-17
07:20
Redeye initiates coverage of RLS Global, a Swedish medtech company that develops unique, high quality wound care products. We believe that the recent actions taken to become a pure wound care company are strategically right and believe that there is a hidden potential in the company’s proprietary buffered hypochlorite platform, from which its wound debridement product ChloraSolv has been developed.
EN
OB
Erik Nordström
Oscar Bergman
Disclosures and disclaimers